These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7725263)

  • 21. Moving ahead or falling behind?
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jun; 4(6):295. PubMed ID: 17541443
    [No Abstract]   [Full Text] [Related]  

  • 22. The place of cisapride in therapeutics: an interim verdict.
    Hawkey CJ
    Aliment Pharmacol Ther; 1991 Aug; 5(4):351-6. PubMed ID: 1777545
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacotherapy of gastrointestinal motor disorders.
    Schuurkes JA
    Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prokinetic agents--their contribution to practice of gastroenterology].
    Hep A; Dolina J
    Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of prokinetic drugs for treatment of postoperative ileus in the horse.
    Dart AJ; Hodgson DR
    Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo-controlled trial of cisapride in postoperative ileus.
    Boghaert A; Haesaert G; Mourisse P; Verlinden M
    Acta Anaesthesiol Belg; 1987; 38(3):195-9. PubMed ID: 3321849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [[The effect of cisapride on the neurogenic bladder].
    Hanson P; Soler JM
    Acta Belg Med Phys; 1989; 12(3):81-8. PubMed ID: 2603597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new prokinetic drug cisapride: pharmacological properties and clinical potential].
    Sheptulin AA; Muradov NN
    Klin Med (Mosk); 1997; 75(7):53-6. PubMed ID: 9411058
    [No Abstract]   [Full Text] [Related]  

  • 32. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
    Dallera F; Scanzi G; Gendarini A
    Clin Ter; 1994 Jan; 144(1):23-6. PubMed ID: 8168347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recurrent gastroparesis following abdominal irradiation. Therapy with cisapride].
    Petrasch S; Layer P; Wehr M; Goebell H
    Z Gastroenterol; 1989 Dec; 27(12):739-42. PubMed ID: 2626854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisapride: a review of the evidence supporting its use in premature infants with feeding intolerance.
    Premji SS; Wilson J; Paes B; Gray S
    Neonatal Netw; 1997 Oct; 16(7):17-21. PubMed ID: 9369691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cisapride (Prepulsid) in the prevention of postoperative gastrointestinal atony].
    Hep A; Prásek J; Filipínský J; Navrátil P; David L; Dolina J; Dítĕ P
    Rozhl Chir; 1998 Mar; 77(3):101-4. PubMed ID: 9623316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse gastrointestinal dysmotility in a patient with rheumatoid arthritis.
    Ljubich P; Parkman HP; Fisher RS; Sorokin JJ; Conaway DC
    Am J Gastroenterol; 1993 Sep; 88(9):1443-5. PubMed ID: 8362846
    [No Abstract]   [Full Text] [Related]  

  • 40. GI motility disorders: diagnostic workup and use of prokinetic therapy.
    Räihä I; Sourander L
    Geriatrics; 1993 Nov; 48(11):57-60, 65-6. PubMed ID: 7901129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.